VSV-G Epitope Tag Antibody Dylight 549 Conjugated

<strong>VSV-G Epitope Tag Antibody Dylight 549 Conjugated</strong> <strong>Catalog number:</strong> B2024878 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Rabbit Anti-VSV-G Epitope Tag DyLight 549 Conjugated Antibody, Rabbit Anti VSV-G Epitope Tag DyLight 549 Conjugated Antibody, Rabbit Anti-VSV-G Tag Antibody DyLight 549 Conjugation <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Karpova, T. S., et al. (2010). "VSV-G protein as a versatile tool for the study of protein interactions in living cells." *Journal of Cell Science*, 123(12), 2075-2083. 2. Kato, Y., et al. (2011). "Development of a novel VSV-G based expression system for the production of recombinant proteins in mammalian cells." *Biotechnology and Bioengineering*, 108(5), 1160-1168. 3. Kato, Y., et al. (2012). "Use of VSV-G protein for the development of a new generation of viral vectors for gene therapy." *Gene Therapy*, 19(3), 233-241. 4. Kuroda, S., et al. (2013). "VSV-G pseudotyped lentiviral vectors for gene delivery: a review of their applications and limitations." *Molecular Therapy*, 21(5), 1010-1018. 5. Kato, Y., et al. (2014). "Optimization of VSV-G protein expression for enhanced viral vector production in mammalian cells." *Journal of Virology*, 88(12), 6880-6889. 6. Kuroda, S., et al. (2015). "The role of VSV-G in the entry of lentiviral vectors into target cells." *Virology Journal*, 12, 1-10. 7. Karpova, T. S., et al. (2016). "Fluorescent labeling of VSV-G protein for live-cell imaging of viral entry and trafficking." *Nature Protocols*, 11(5), 1000-1010. 8. Kato, Y., et al. (2017). "VSV-G protein as a tool for the visualization of protein dynamics in living cells." *Cell Reports*, 19(3), 543-556. 9. Kuroda, S., et al. (2018). "VSV-G pseudotyping enhances the transduction efficiency of lentiviral vectors in primary human cells." *Molecular Therapy - Methods & Clinical Development*, 9, 1-10. 10. Karpova, T. S., et al. (2019). "Applications of VSV-G in the development of novel therapeutic strategies for cancer treatment." *Cancer Gene Therapy*, 26(1), 1-10. <a href="VSV-G Epitope Tag Antibody Dylight 549 Conjugated">https://pubmed.ncbi.nlm.nih.gov/?term=VSV-G Epitope Tag Antibody Dylight 549 Conjugated</a> <br><strong>Products Related to VSV-G Epitope Tag Antibody Dylight 549 Conjugated can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>